Racial Loyalty News

Racial Loyalty News => General News => Topic started by: GLR on 23 January 2022 at 19:32

Title: Moderna Stock Crashes, Loses $130 Billion & Stock Down 67%
Post by: Private on 23 January 2022 at 19:32
Moderna Stock Crashes – Losses Top $130 Billion, Stock Down 67% from Highs Last Year Following Lackluster COVID Vaccine Results

January 22, 2022

(https://media.gab.com/system/media_attachments/files/096/633/242/small/d2e40409b6e672bc.png)

 Moderna stocks plunged on Friday during the market selloff  this week. The company has lost $130 billion in value this year over the  lackluster COVID vaccine results with the new Omicron variant. The  stock is down 67% from its all-rime high last year. Battered by a steep broad-market selloff this week, Moderna shares  fell for a sixth straight day Friday as experts questioned whether  Covid-19 vaccine sales alone will help justify the firm’s meteoric  valuation, intensifying a crash that’s wiped out more than 60% of the  value in one of last year’s top stocks and turned it into this year’s  worst performer. 
 
(https://media.gab.com/system/media_attachments/files/096/633/009/small/3bea26f391f13b25.png)
*
Moderna stock fell 4.4% Friday to an eight-month low of $160, pushing shares down more than 20% over the past week amid growing research suggesting Moderna’s Covid-19 booster, while very effective against previous strains, has been less effective against the rapidly spreading omicron variant…  Shares of Moderna have plunged 67% from an all-time closing high of $484 on August 9, wiping out about $133 billion from the firm’s market capitalization, which now stands at roughly $65 billion.
 
Moderna Stock Crashes - Losses Top $130 Billion, Stock Down 67% from Highs Last Year Following Lackluster COVID Vaccine Results (https://www.thegatewaypundit.com/2022/01/moderna-stock-crashes-losses-top-130-billion-stock-67-highs-last-year-following-lackluster-covid-vaccine-results/)
https://www.thegatewaypundit.com/2022/01/moderna-stock-crashes-losses-top-130-billion-stock-67-highs-last-year-following-lackluster-covid-vaccine-results